ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study (VOG-HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02563418
Recruitment Status : Unknown
Verified September 2015 by University Hospital, Angers.
Recruitment status was:  Recruiting
First Posted : September 30, 2015
Last Update Posted : September 30, 2015
Sponsor:
Information provided by (Responsible Party):
University Hospital, Angers

Brief Summary:
The purpose of this study is to know the limits of feasibility of a reliable oculomotor record for patient with Huntington's disease.

Condition or disease Intervention/treatment Phase
Huntington Disease Device: Eye-tracking Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Study Start Date : May 2014
Estimated Primary Completion Date : May 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Patient with Huntington's disease Device: Eye-tracking



Primary Outcome Measures :
  1. saccadic measures with the eye tracker [ Time Frame: 1 day ]
    one measure in the evening and one in the afternoon



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Corrected visual acuity >1/10
  • Aged over 18 years
  • Patient with the mutation that is to say the presence of an abnormal number of trinuclide: CAG> 38 in the first exon of the huntingtin gene.
  • Total Functional Capacity Scale (CFT) ≥ 3

Exclusion Criteria:

  • Patients or trustworthy person who have not given their written consent, informed and signed.
  • Patients are not affiliated or who are not entitled to Social Security
  • Private patients of liberty by administrative or judicial decision, or patients supervision
  • Associated disease with neurological repercussions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02563418


Contacts
Contact: Sophie Hue 33 (0)241353800 sophie.hue@chu-angers.fr

Locations
France
Centre Hospitalier Universitaire Recruiting
Angers, France, 49000
Contact: D Milea       damilea@chu-angers.fr   
Sponsors and Collaborators
University Hospital, Angers

Responsible Party: University Hospital, Angers
ClinicalTrials.gov Identifier: NCT02563418     History of Changes
Other Study ID Numbers: AOI 2013 - 11
First Posted: September 30, 2015    Key Record Dates
Last Update Posted: September 30, 2015
Last Verified: September 2015

Keywords provided by University Hospital, Angers:
video oculography

Additional relevant MeSH terms:
Huntington Disease
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Genetic Diseases, Inborn
Cognition Disorders
Neurocognitive Disorders
Mental Disorders
Dementia
Chorea
Dyskinesias